GSK signs outsourcing deal with TCS
GSK already has sizeable research operations in Mumbai and Bangalore and employs 2,400 people in India.
By PTI |
London: GlaxoSmithKline, Britain's largest drug company, has signed an outsourcing agreement with Tata Consulting Services of India to establish a drug development support facility in Mumbai.
Under the terms of the deal, TCS will support GSK's global clinical research and development programme by providing outsourced data management and medical trial reporting services. The arrangement will create nearly 100 new jobs on an existing site and is understood to be worth more than 10 million pounds.
GSK already has sizeable research operations in Mumbai and Bangalore and employs 2,400 people in India, where it controls 5.9 per cent of the pharmaceuticals market.
Amber Salzman, senior vice-President of the development operations at GSK said in a statement that the company had picked TCS as a partner because of its strong record in knowledge process outsourcing and operational excellence.
Like many global companies GSK has been seeking to tap into India's pool of high-quality IT and scientific talent and is aiming to trim costs through outsourcing.
GSK is also involved in a research collaboration with Ranbaxy Laboratories, India's largest drug-maker, to jointly develop drugs in areas such as urology, diabetes and asthma.
Under the terms of the deal, TCS will support GSK's global clinical research and development programme by providing outsourced data management and medical trial reporting services. The arrangement will create nearly 100 new jobs on an existing site and is understood to be worth more than 10 million pounds.
GSK already has sizeable research operations in Mumbai and Bangalore and employs 2,400 people in India, where it controls 5.9 per cent of the pharmaceuticals market.
Amber Salzman, senior vice-President of the development operations at GSK said in a statement that the company had picked TCS as a partner because of its strong record in knowledge process outsourcing and operational excellence.
Like many global companies GSK has been seeking to tap into India's pool of high-quality IT and scientific talent and is aiming to trim costs through outsourcing.
GSK is also involved in a research collaboration with Ranbaxy Laboratories, India's largest drug-maker, to jointly develop drugs in areas such as urology, diabetes and asthma.
Start a SIP with as low as ₹500 with ET Money App!
Download
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
ADVERTISEMENT
